Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.38
-0.0100-0.72%
Post-market: 1.380.00000.00%16:10 EDT
Volume:148.33K
Turnover:202.73K
Market Cap:82.49M
PE:-0.43
High:1.45
Open:1.37
Low:1.31
Close:1.39
Loading ...
Jan 29, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 13, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 16, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 15, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 11, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 09, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 05, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 18, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 06, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2020

Major Issues Report

8-K - Current report
Jun 12, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01